Notices. Notification of affirmation
144 words·~1 min read·
/register/2017/08/23/2017-17961·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2013-E-0264; FDA-2013-E-0263; and FDA-2013-E-0218] Determination of Regulatory Review Period for Purposes of Patent Extension; RECUVYRA; Affirmation AGENCY: Food and Drug Administration, HHS. ACTION: Notification of affirmation. DATES: August 23, 2017 FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, 10903 New Hampshire Ave., Bldg. 51, Silver Spring, MD 20993, 301-796-9148. SUPPLEMENTARY INFORMATION: The Food and Drug Administration
(FDA)is affirming the signature date for a notice that appeared in the **Federal Register** on August 21, 2017 (82 FR 39587). The document announced FDA's determination for the regulatory review period for RECUVYRA. The document published with an incorrect date for the signature. We affirm that the document was signed on August 15, 2017. Dated: August 21, 2017. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2017-17961 Filed 8-21-17; 4:15 pm]